With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

The US Food and Drug Administration (FDA) recently issued its draft guidance, Considerations for the Use of Artificial Intelligence to ...

The industry is grappling with significant market shifts amidst emerging technologies and changing demands. Companies are now producing increasingly personalised and sophisticated therapies, ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain ...

With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...

XtalPi says AI is reducing drug discovery times to two years from four XtalPi Holdings, an artificial intelligence (AI) drug ...

Purdue partners with Eli Lilly and Merck to launch the Young Institute Pharmaceutical Manufacturing Consortium, focusing on sterile injectables.

Gary Drenik is a writer covering AI, analytics and innovation. As of 2023, the pharmaceutical industry has boosted ... Mark shares his insights into how the use of RWD in the pharma advertising ...